Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Marone

Showing results (211-220 of 243) with videos related to

Pageof 25
Sort By:
Anesthesiology|November 1, 1992
Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator releaseC Stellato, R Cirillo, A de Paulis, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1987
Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfateM D Tharp, A Kagey-Sobotka, C C Fox, et al.
Biochemical Pharmacology|January 15, 1990
Modulation of mediator release from human basophils and pulmonary mast cells and macrophages by auranofinM Columbo, D Galeone, G Guidi, et al.
The American Journal of Pathology|October 9, 1999
Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokinesP Romagnani, A De Paulis, C Beltrame, et al.
Blood|June 1, 1978
Role of the hypophysis in erythropoietin production during hypoxiaC Peschle, I A Rappaport, M C Magli, et al.
The Journal of Clinical Investigation|June 1, 1994
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factorG Ambrosio, A Oriente, C Napoli, et al.
International Archives of Allergy and Immunology|April 18, 2001
Expression of the chemokine receptor CCR3 on human mast cellsA de Paulis, F Annunziato, L Di Gioia, et al.
Arthritis and Rheumatism|July 1, 1996
Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterizationA de Paulis, I MarinĂ², A Ciccarelli, et al.
Molecular Pharmacology|July 11, 1998
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistaminesM Taglialatela, A Pannaccione, P Castaldo, et al.
International Journal of Clinical & Laboratory Research|May 22, 1998
Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosusA Postiglione, S De Chiara, A Soricelli, et al.
Pageof 25

Showing results (211-220 of 243) with videos related to

Sort By:
Pageof 25
Anesthesiology|November 1, 1992
Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator releaseC Stellato, R Cirillo, A de Paulis, et al.
The Journal of Allergy and Clinical Immunology|April 1, 1987
Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfateM D Tharp, A Kagey-Sobotka, C C Fox, et al.
Biochemical Pharmacology|January 15, 1990
Modulation of mediator release from human basophils and pulmonary mast cells and macrophages by auranofinM Columbo, D Galeone, G Guidi, et al.
The American Journal of Pathology|October 9, 1999
Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokinesP Romagnani, A De Paulis, C Beltrame, et al.
Blood|June 1, 1978
Role of the hypophysis in erythropoietin production during hypoxiaC Peschle, I A Rappaport, M C Magli, et al.
The Journal of Clinical Investigation|June 1, 1994
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factorG Ambrosio, A Oriente, C Napoli, et al.
International Archives of Allergy and Immunology|April 18, 2001
Expression of the chemokine receptor CCR3 on human mast cellsA de Paulis, F Annunziato, L Di Gioia, et al.
Arthritis and Rheumatism|July 1, 1996
Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterizationA de Paulis, I MarinĂ², A Ciccarelli, et al.
Molecular Pharmacology|July 11, 1998
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistaminesM Taglialatela, A Pannaccione, P Castaldo, et al.
International Journal of Clinical & Laboratory Research|May 22, 1998
Alterations of cerebral blood flow and antiphospholipid antibodies in patients with systemic lupus erythematosusA Postiglione, S De Chiara, A Soricelli, et al.
Pageof 25